RICHMOND, Va.--(BUSINESS WIRE)--Insmed Inc. (Nasdaq:INSM), a biopharmaceutical company focused on the development and approval of drugs for the treatment of metabolic diseases with unmet medical needs and the development of a comprehensive portfolio of follow on biologics, today announced that it will present at the 2007 BIO Investor Forum in San Francisco.
